Bayesian Capital Management, LP Perkinelmer Inc Transaction History

Bayesian Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	N/A	34,922 New	34,922 $4.23 Million
Q3 2023 Nov 14, 2023	BUY	$115.88 - $122.81 $869,100 - $921,075	7,500 New	7,500 $907,000
Q1 2023 May 15, 2023	SELL	$120.16 - $144.38 $901,200 - $1.08 Million	-7,500 Reduced 53.38%	6,550 $872,000
Q4 2022 Feb 14, 2023	BUY	$119.0 - $147.98 $1.24 Million - $1.54 Million	10,400 Added 284.93%	14,050 $1.97 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $160.96 $430,955 - $587,504	3,650 New	3,650 $439,000
Q2 2022 Aug 15, 2022	SELL	$134.91 - $172.49 $188,874 - $241,486	-1,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$162.31 - $192.2 $227,234 - $269,080	1,400 New	1,400 $244,000
Q2 2021 Aug 13, 2021	SELL	$127.81 - $155.84 $1.06 Million - $1.29 Million	-8,300 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$120.35 - $160.53 $288,840 - $385,272	2,400 Added 40.68%	8,300 $1.07 Million
Q4 2020 Feb 12, 2021	BUY	$122.05 - $147.91 $720,095 - $872,669	5,900 New	5,900 $847,000

576

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.